The Great American Smokeout

The American Cancer Society marks the Great American Smokeout on the third Thursday of November each year by encouraging smokers to use the date to make a plan to quit, or to plan in advance and quit smoking that day. By quitting — even for one day — smokers will be taking an important step towards a healthier life – one that can lead to reducing cancer risk.

Older Women With Breathing Problems During Sleep

Older women with disordered breathing during sleep were found to be at greater risk of decline in the ability to perform daily activities, such as grocery shopping and meal preparation, according to research led by researchers at the Johns Hopkins Bloomberg School of Public Health and the University of California, San Francisco. The study was published November 6th 2014 in the online edition of the Journal of the American Geriatrics Society.

Nanobodies: A Smaller Weapon in Fighting Disease

A new system developed by researchers at Rockefeller University promises to make nanobodies, proteins that flag diseased cells for destruction, more accessible for various kinds of research.

Nanobodies are “cousins” to antibodies and can perform similar tasks such as marking molecules for research or discovering diseased cells. They are much simpler to produce than antibodies, but until this most recent study experts haven’t been able to recognize which nanobodies are most in tune with their “targets.”

Going Gluten-Free: A Mayo Clinic Expert Explains The Most Common Myths

Misinformation abounds when it comes to celiac disease and gluten-free eating. But an estimated 1 in 141 Americans has celiac disease, and countless more may be sensitive to gluten. Unfortunately, many people with celiac disease are misdiagnosed or do not know they have the condition because its symptoms are often varied and subtle. Moreover, “gluten-free” has become a very common term in our society, appearing on food packages and menus everywhere. Some may view it as a fad, but celiac disease and related conditions are serious- and confusing!

One Molecule, Many Illnesses

Researchers have identified what seems to be a molecular “switch” that controls inflammatory processes linked to a number of conditions including muscle atrophy and Alzheimer’s disease.

The study, led by Massachusetts General Hospital (MGH) investigators, found that the action of the signaling molecule, nitric oxide, on the protein SIRT1, appears to be necessary for the introduction of inflammation and cell death in several aging-related disorders.


About Us

For over a decade, ThirdAge has been a leading source of information for "boomer and beyond" women. Our writers cover what means most to women 50+: the empty nest, living solo, finding love, coping with caregiving, and remaking their lives the way they want them to be. We also feature the latest approaches to brain fitness, diet, exercise, and age-related health conditions.